Get your free report card.

See how your commercial strategy stacks up — for your full portfolio or a single company. Scored across four dimensions, benchmarked against 700+ companies. Free. 48 hours.

See where your portfolio stands.

Tell us about your fund and we'll score your portfolio companies' commercial health — independent, data-driven, and benchmarked against 700+ companies.

Free. No credit card. No sales call required.

By submitting your information you agree to our Privacy Policy and Terms of Service.

Sample Portfolio Report Card

We score every company in your portfolio and deliver a fund-level commercial health snapshot.

Apex Growth Partners
Fund II · 8 Active Companies
Remidi
61 / 100
Portfolio Average
Universe Avg: 62 · Winner Avg: 73
3 of 8 companies below winner threshold
Competitive Disadvantage Rate
38%
3 of 8 companies have suboptimized commercial strategies.
Scoring below 60 — where winner odds drop below 35%.
Portfolio Distribution
0
Rebuild
0–29
1
Attention
30–45
2
Developing
46–65
5
Mkt Ready
66–100
Portfolio Gaps vs. Winners
Trust & Credibility
58
Pricing & Packaging
53
Buyer Experience
71
Messaging & Positioning
62
Portfolio-Level Opportunities
Critical 3 companies lack any customer proof — no case studies, no testimonials, no logos.
High 5 of 8 companies hide pricing — creating friction before the first sales conversation.
Portfolio avg · Distribution · Dimension gaps · Company-by-company scores · Top actions · Benchmarked vs. 700+